zandelisib
Showing 1 - 3 of 3
Relapsed Follicular Lymphoma, Refractory Follicular Lymphoma Trial in Boston (TAZEMETOSTAT, Zandelisib)
Not yet recruiting
- Relapsed Follicular Lymphoma
- Refractory Follicular Lymphoma
- TAZEMETOSTAT
- Zandelisib
-
Boston, Massachusetts
- +1 more
Oct 28, 2022
CLL Trial in Stony Brook, Oklahoma City (Zandelisib, Rituximab, Venetoclax)
Recruiting
- CLL
- Zandelisib
- +2 more
-
Stony Brook, New York
- +1 more
May 12, 2022
Follicular Lymphoma (FL), Non Hodgkin Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (Zandelisib, Rituximab, Bendamustine)
Recruiting
- Follicular Lymphoma (FL)
- +2 more
- Zandelisib
- +3 more
-
Tucson, Arizona
- +134 more
Jul 27, 2022